Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.

Hdl Handle:
http://hdl.handle.net/10144/235558
Title:
Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.
Authors:
Isaakidis, Petros; Varghese, Bhanumati; Mansoor, Homa; Cox, Helen S; Ladomirska, Joanna; Saranchuk, Peter; Da Silva, Esdras; Khan, Samsuddin; Paryani, Roma; Udwadia, Zarir; Migliori, Giovanni Battista; Sotgiu, Giovanni; Reid, Tony
Journal:
PloS One
Abstract:
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.
Affiliation:
Médecins Sans Frontières, Mumbai, India.
Publisher:
PLoS
Issue Date:
Jul-2012
URI:
http://hdl.handle.net/10144/235558
DOI:
10.1371/journal.pone.0040781
PubMed ID:
22792406
Language:
en
ISSN:
1932-6203
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorIsaakidis, Petrosen_GB
dc.contributor.authorVarghese, Bhanumatien_GB
dc.contributor.authorMansoor, Homaen_GB
dc.contributor.authorCox, Helen Sen_GB
dc.contributor.authorLadomirska, Joannaen_GB
dc.contributor.authorSaranchuk, Peteren_GB
dc.contributor.authorDa Silva, Esdrasen_GB
dc.contributor.authorKhan, Samsuddinen_GB
dc.contributor.authorParyani, Romaen_GB
dc.contributor.authorUdwadia, Zariren_GB
dc.contributor.authorMigliori, Giovanni Battistaen_GB
dc.contributor.authorSotgiu, Giovannien_GB
dc.contributor.authorReid, Tonyen_GB
dc.date.accessioned2012-07-24T14:45:24Z-
dc.date.available2012-07-24T14:45:24Z-
dc.date.issued2012-07-
dc.identifier.citationAdverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. 2012, 7 (7):e40781 PLoS ONEen_GB
dc.identifier.issn1932-6203-
dc.identifier.pmid22792406-
dc.identifier.doi10.1371/journal.pone.0040781-
dc.identifier.urihttp://hdl.handle.net/10144/235558-
dc.description.abstractSignificant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.en_GB
dc.language.isoenen
dc.publisherPLoSen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.titleAdverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.en
dc.contributor.departmentMédecins Sans Frontières, Mumbai, India.en_GB
dc.identifier.journalPloS Oneen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.